I tend to agree with that assessment. It makes all the sense in the world to me. But, just don't understand why DF would have ordered the early testing as Leo relayed to us back in the Spring. Perhaps someone higher up nixed the order. We just don't have enough good intel to know why it isn't being done. Might make a fine book one day to tell the story of K and how it actually happened.
IMO, DF won't release any PK/PD or biomarker data related to the clinical trial until the new lab director is fully up to speed and the labs work their way through the backlog to the Kevetrin trial samples and biopsies. I don't think anyone, including Harvard, realized the lurch that the loss of Dr. Edward Fox would leave for all dependent on him and his labs. I hope I'm wrong, but that is the reality I see.
News 
Market Data 
Discover 
AI
